SCHEMBL19934850

SCHEMBL19934850

O=C1c2ccc(O)cc2-c2c(-c3cccc(O)c3)oc3cc(O)cc1c23

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 3/20 0.47
▸ DHFR P00374 1/20 0.47
▸ KCNH2 Q12809 1/20 0.47
▸ MEN1 O00255 7/20 0.46
▸ KMT2A Q03164 7/20 0.46
▸ POLH Q9Y253 2/20 0.46
▸ HSP90AA1 P07900 1/20 0.46
▸ CYP3A4 P08684 8/20 0.46
▸ MAPT P10636 8/20 0.46
▸ CYP2C9 P11712 5/20 0.46
▸ ALDH1A1 P00352 5/20 0.46
▸ HPGD P15428 5/20 0.46
▸ KDM4E B2RXH2 4/20 0.46
▸ HSD17B10 Q99714 4/20 0.46
▸ XDH P47989 3/20 0.46
▸ FTO Q9C0B1 3/20 0.46
▸ BACE1 P56817 3/20 0.46
▸ TP53 P04637 3/20 0.46
▸ ALOX15 P16050 3/20 0.46
▸ MPG P29372 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19929832 0.90 CA12 (0.49) CYP1A2DHFRKCNH2MEN1KMT2A
SCHEMBL19929827 0.88 KDM4E (0.51) CYP1A2MEN1KMT2APOLHHSP90AA1
SCHEMBL19934851 0.83 KDM4E (0.51) CYP1A2MEN1KMT2APOLHHSP90AA1
SCHEMBL19929824 0.82 APP (0.56) CYP1A2MEN1KMT2APOLHHSP90AA1
SCHEMBL19929831 0.82 MEN1 (0.51) CYP1A2MEN1KMT2APOLHHSP90AA1
SCHEMBL19929830 0.79 MIF (0.46) CYP1A2MEN1KMT2APOLHHSP90AA1
SCHEMBL19929835 0.76 CYP3A4 (0.50) CYP1A2MEN1KMT2APOLHHSP90AA1
SCHEMBL19934849 0.76 CYP3A4 (0.50) CYP1A2MEN1KMT2APOLHHSP90AA1
SCHEMBL19929829 0.75 MEN1 (0.64) CYP1A2MEN1KMT2APOLHHSP90AA1
SCHEMBL29732709 0.74 CYP3A4 (0.57) CYP1A2MEN1KMT2APOLHHSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10508092-B2 Synthesis of novel analogs of diptoindonesin G, compounds formed thereby, and pharmaceutical compositions containing them WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2019-12-17 — — US disclosed
US-20180065945-A1 SYNTHESIS OF NOVEL ANALOGS OF DIPTOINDONESIN G, COMPOUNDS FORMED THEREBY, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM THE GOVERNMENT OF THE UNITED STATES, AS REPRESENTED BY THE SECRETARY OF THE ARMY 2018-03-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180065945-A1 SYNTHESIS OF NOVEL ANALOGS OF DIPTOINDONESIN G, COMPOUNDS FORMED THEREBY, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM HPGDS, DPP7, DPEP1 CYP1A2 1976/4885DHFR 532/4885KCNH2 3411/4885
US-10508092-B2 Synthesis of novel analogs of diptoindonesin G, compounds formed thereby, and pharmaceutical compositions containing them HPGDS, DPP7, DPEP1 CYP1A2 1976/4885DHFR 532/4885KCNH2 3411/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback